Synonyms: Amikin® | AMK | Arikayce liposomal® | BB-K8
amikacin is an approved drug (FDA (1981), EMA (2020))
Compound class:
Synthetic organic
Comment: Amikacin is a semi-synthetic aminoglycoside antibacterial that is active against a broad spectrum of Gram-negative organisms, including pseudomonas and some Gram-positive organisms (principally Staphylococcus aureus, including some methicillin-resistant strains). It is a kanamycin derivative. Functionally it binds to the bacterial 30S ribosomal subunit and disrupts protein synthesis, thereby creating its bactericidal effect.
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (1981), EMA (2020)) |
WHO Essential Medicine | WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version. Click to view more information about the WHO Model Lists of Essential Medicines. |
International Nonproprietary Names | |
INN number | INN |
3492 | amikacin |
Synonyms |
Amikin® | AMK | Arikayce liposomal® | BB-K8 |
Database Links | |
Specialist databases | |
Antibiotic DB | Amikacin |
Other databases | |
BindingDB Ligand | 50237603 |
CAS Registry No. | 37517-28-5 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL177 |
DrugBank Ligand | DB00479 |
DrugCentral Ligand | 157 |
GtoPdb PubChem SID | 405560335 |
PubChem CID | 37768 |
RCSB PDB Ligand | AKN |
Search Google for chemical match using the InChIKey | LKCWBDHBTVXHDL-RMDFUYIESA-N |
Search Google for chemicals with the same backbone | LKCWBDHBTVXHDL |
Search PubMed clinical trials | amikacin |
Search PubMed titles | amikacin |
Search PubMed titles/abstracts | amikacin |
UniChem Compound Search for chemical match using the InChIKey | LKCWBDHBTVXHDL-RMDFUYIESA-N |
UniChem Connectivity Search for chemical match using the InChIKey | LKCWBDHBTVXHDL-RMDFUYIESA-N |